chemotherapy calculation - YouTube
Effect of body mass index on pharmacokinetics of paclitaxel in patients with early breast cancer - Gota - 2021 - Cancer Medicine - Wiley Online Library
160-Breast adjuvant PACLitaxel dose dense | eviQ
Optimal dose reduction of FOLFIRINOX for preserving tumour response in advanced pancreatic cancer: Using cumulative relative dose intensity - ScienceDirect
Paclitaxel | CAS:33069-62-4 | Antineoplastic agent | Diterpenoids | High Purity | Manufacturer BioCrick
Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel Micellar in Patients with Recurrent Malignant Solid Tumours: A Dose-Escalation Study | SpringerLink
8. Calculation of Doses- Patient Parameters.ppt [相容模式]
Carboplatin Dosing in Overweight and Obese Patients: A Single-Center Experience
Paclitaxel and Cyclophosphamide Dose Levels | Download Table
How to calculate the dose of chemotherapy | British Journal of Cancer
Paclitaxel exposure-toxicity analysis reveals a pharmacokinetic determinant for dose-limiting neutropenia in East-Asian solid tumor patients: results from two prospective, phase II studies | SpringerLink
Paclitaxel | C47H51NO14 - PubChem
PDF) How to calculate the dose of chemotherapy
Carboplatin Calculator | Calvert Formula
8. Calculation of Doses- Patient Parameters.ppt [相容模式]
Taxol (paclitaxel) dosing, indications, interactions, adverse effects, and more
4103-Breast adjuvant/neoadjuvant PACLitaxel weekly | eviQ
Effect of body mass index on pharmacokinetics of paclitaxel in patients with early breast cancer - Gota - 2021 - Cancer Medicine - Wiley Online Library
Preclinical tolerance evaluation of the addition of a cisplatin-based dry powder for inhalation to the conventional carboplatin-paclitaxel doublet for treatment of non-small cell lung cancer - ScienceDirect
PDF) Standardization and Scoring of the Body Surface Area (BSA) Formulas for Calculation of the Doses of Anticancer Agents for Cancer Patients from the North-Western Nigeria
Randomized study of individualized pharmacokinetically‐guided dosing of paclitaxel compared with body‐surface area dosing in Chinese patients with advanced non‐small cell lung cancer - Zhang - 2019 - British Journal of Clinical Pharmacology -
A Dose Finding Study of Weekly and Every-3-Week nab-Paclitaxel Followed by Carboplatin as First-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer - ScienceDirect
Bioline International Official Site (site up-dated regularly)
